Harimata Company

Harimata develops innovative, scientifically-validated technologies supporting early assessment and therapy of developmental disorders in children like autism, ADHD/ADD, intellectual disability. They specialise in combining experimental psychology with artificial intelligence. Their research and development projects are conducted in line with the highest scientific standards. Their product Play.Care is a tablet-based screening test supporting early detection of autism and other neurodevelopmental disorders in children aged 2–6.

Founded Date: 2013
Technology: Intelligent Data Analysis
Investor Type: N/A
Funding Status: Seed
Headquarters: Kraków, Poland
Investment Stage: N/A
Number Of Exists: N/A
Industry: Health Care